Contact this trialFirst, we need to learn more about you.
Sphingosine 1-phosphate receptor modulator
RPC1063 for Ulcerative Colitis
Recruiting2 awardsPhase 3
San Francisco, California
This trial will test the long-term safety and effectiveness of a drug called RPC1063 in people with ulcerative colitis.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.